Bicarbonate

Bicarbonate

SCHEMBL10758910

N=C(N)NCc1ccncc1.O.O=C(O)O

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.53
▸ GAA P10253 3/20 0.53
▸ MAPT P10636 1/20 0.53
▸ HTT P42858 2/20 0.51
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ MMP13 P45452 1/20 0.49
▸ HSD17B10 Q99714 1/20 0.49
▸ NAMPT P43490 2/20 0.48
▸ LMNA P02545 1/20 0.48
▸ RAB9A P51151 1/20 0.47
▸ CA2 P00918 1/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ CYP3A4 P08684 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10310272 0.91 ALDH1A1 (0.47) ALDH1A1GAAMAPTHTTSMN1; SMN2
Bicarbonate SCHEMBL27358699 0.82 CYP2D6 (0.56) ALDH1A1GAASMN1; SMN2LMNACA2
Carbamic Acid SCHEMBL31088316 0.80 GAA (0.58) ALDH1A1GAAMAPTHTTSMN1; SMN2
SCHEMBL6929919 0.80 RECQL (0.62) ALDH1A1GAAMAPTHTTSMN1; SMN2
Hydrochloric Acid SCHEMBL6557760 0.78 KDM4E (0.58) GAAMAPTNAMPTKDM4E
Iodide SCHEMBL20524285 0.78 RECQL (0.61) ALDH1A1GAAMAPTHTTSMN1; SMN2
SCHEMBL11097818 0.78 ALDH1A1 (0.51) ALDH1A1GAAMAPTHTTSMN1; SMN2
SCHEMBL334662 0.77 GAA (0.64) ALDH1A1GAAMAPTHTTSMN1; SMN2
SCHEMBL30437853 0.77 GAA (0.64) ALDH1A1GAAMAPTHTTSMN1; SMN2
SCHEMBL10405358 0.77 ALDH1A1 (0.58) ALDH1A1GAAMAPTHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4707478-A ANTIPROTOZOA AGENTS RORER PHARMACEUTICAL CORPORATION (US) 1987-11-17 — — US disclosed
EP-0086775-A4 HETEROCYCLIC AMIDINO SUBSTITUTED UREAS AND THEIR PHARMACEUTICAL USES. RORER INTERNAT OVERSEAS INC (US) 1984-09-05 — — EP disclosed
EP-0086775-A1 HETEROCYCLIC AMIDINO SUBSTITUTED UREAS AND THEIR PHARMACEUTICAL USES RORER INTERNATIONAL (OVERSEAS) INC. (US) 1983-08-31 — — EP disclosed
WO-1983000627-A1 HETEROCYCLIC AMIDINO SUBSTITUTED UREAS AND THEIR PHARMACEUTICAL USES STUDT, WILLIAM, LYON 1983-03-03 — — WO disclosed
Send feedback